The pharmaceutical sector has always fac heavy regulation when it comes to brand and product communication. Marketing managers rely solely on traditional advertising, sales reps and the mia, which often turn companies and products into villains or misposition a particular mication, causing more disruption to the image and consumer perception than boosting sales. How can you create a content marketing strategy in the pharmaceutical sector that communicates a valuable message to key stakeholders?
The remy for this pain is content marketing for the pharmaceutical sector – which opens a direct path of communication between companies, patients finland email list 919532 contact leads and healthcare professionals, enabling the opening of a new frontier of communication between companies and their different stakeholders.
The regulatory landscape
The pharmaceutical industry faces a series of prohibitions and regulations regarding communication with customers. Add to these challenges are other objectives that are common to any marketing professional: differentiation from the competition, alignment of marketing with business objectives, and the difficulty in attracting and retaining new consumers.
Regulation involves a series of aspects, making communication between these companies very complex. The market is highly regulat, and the entire sector is monitor by government agencies that aim to ensure consumer safety, as well as preventing everyone must collect analytics self-mication, for example, by proving the transmission of crible and scientific information, bas on data that can be verifi – and, of course, publish in a clear manner that can be understood by as many people as possible.
Pharmaceutical industry marketing professionals also have to deal with a very delicate aspect of their work: how to approach a disease, how to talk about life expectancy or a better quality of life, to a patient who is generally sensitive to a disease, both physically and psychologically? How to go beyond the stigma of some health conditions, creating a story that transcends the barriers of prejudice.
B2C or B2B?
Another point that sets the pharmaceutical industry apart philippines numbers from other sectors is that these companies ne to communicate directly with their consumers, but they also ne to sell their micines to agents who miate this sale: pharmacies. Another stakeholder in this scenario is the doctor – who, in addition to recommending the mication, will transform add values into that brand, such as trust, seriousness, and scientificity, which are essential for the pharmaceutical industry.
In any case, the pharmaceutical market in Brazil is huge. To give you an idea, according to data from PwC, drug sales in Brazil reach US$25.8 billion in retail sales – of this total, at least US$18.3 billion in sales are link to prescription drugs.